Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 58

1.

Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide.

Sukumar UK, Bose RJC, Malhotra M, Babikir HA, Afjei R, Robinson E, Zeng Y, Chang E, Habte F, Sinclair R, Gambhir SS, Massoud TF, Paulmurugan R.

Biomaterials. 2019 Oct;218:119342. doi: 10.1016/j.biomaterials.2019.119342. Epub 2019 Jul 12.

PMID:
31326657
2.

The protean world of non-coding RNAs in glioblastoma.

Paulmurugan R, Malhotra M, Massoud TF.

J Mol Med (Berl). 2019 Jul;97(7):909-925. doi: 10.1007/s00109-019-01798-6. Epub 2019 May 25. Review.

PMID:
31129756
3.

Analytical Validation of a Single-Nucleotide Polymorphism-Based Donor-Derived Cell-Free DNA Assay for Detecting Rejection in Kidney Transplant Patients.

Altu─č Y, Liang N, Ram R, Ravi H, Ahmed E, Brevnov M, Swenerton R, Zimmermann B, Malhotra M, Demko ZP, Billings PR, Ryan A.

Transplantation. 2019 Feb 19. doi: 10.1097/TP.0000000000002665. [Epub ahead of print]

PMID:
30801536
4.

Fine needle aspiration of a superficial scalp swelling with a deeper connection.

Mundi I, Pankaj R, Malhotra M.

Diagn Cytopathol. 2018 Nov;46(11):981-982. doi: 10.1002/dc.24031. No abstract available.

PMID:
30488671
5.

Targeted nanoparticle delivery of therapeutic antisense microRNAs presensitizes glioblastoma cells to lower effective doses of temozolomide in vitro and in a mouse model.

Malhotra M, Sekar TV, Ananta JS, Devulapally R, Afjei R, Babikir HA, Paulmurugan R, Massoud TF.

Oncotarget. 2018 Apr 20;9(30):21478-21494. doi: 10.18632/oncotarget.25135. eCollection 2018 Apr 20.

6.

Cyclodextrin-siRNA conjugates as versatile gene silencing agents.

Malhotra M, Gooding M, Evans JC, O'Driscoll D, Darcy R, O'Driscoll CM.

Eur J Pharm Sci. 2018 Mar 1;114:30-37. doi: 10.1016/j.ejps.2017.11.024. Epub 2017 Nov 27.

PMID:
29191522
7.

Folate-targeted amphiphilic cyclodextrin nanoparticles incorporating a fusogenic peptide deliver therapeutic siRNA and inhibit the invasive capacity of 3D prostate cancer tumours.

Evans JC, Malhotra M, Sweeney K, Darcy R, Nelson CC, Hollier BG, O'Driscoll CM.

Int J Pharm. 2017 Oct 30;532(1):511-518. doi: 10.1016/j.ijpharm.2017.09.013. Epub 2017 Sep 13.

PMID:
28916296
8.

Novel Milrinone Nanoformulation for Use in Cardiovascular Diseases: Preparation and in Vitro Characterization.

Lomis N, Gaudreault F, Malhotra M, Westfall S, Shum-Tim D, Prakash S.

Mol Pharm. 2018 Jul 2;15(7):2489-2502. doi: 10.1021/acs.molpharmaceut.7b00360. Epub 2018 Jun 8.

PMID:
28837343
9.

Peripheral blood smear: beyond routine morphology.

Mundi I, Pankaj R, Bedi R, Sharma A, Malhotra M.

Trop Doct. 2017 Oct;47(4):382-384. doi: 10.1177/0049475517701877. Epub 2017 Apr 18. No abstract available.

PMID:
28420290
10.

Formulation and Evaluation of Anisamide-Targeted Amphiphilic Cyclodextrin Nanoparticles To Promote Therapeutic Gene Silencing in a 3D Prostate Cancer Bone Metastases Model.

Evans JC, Malhotra M, Fitzgerald KA, Guo J, Cronin MF, Curtin CM, O'Brien FJ, Darcy R, O'Driscoll CM.

Mol Pharm. 2017 Jan 3;14(1):42-52. doi: 10.1021/acs.molpharmaceut.6b00646. Epub 2016 Nov 23.

PMID:
28043128
11.

Design and validation of an orally administrated active L. fermentum-L. acidophilus probiotic formulation using colorectal cancer Apc Min/+ mouse model.

Kahouli I, Malhotra M, Westfall S, Alaoui-Jamali MA, Prakash S.

Appl Microbiol Biotechnol. 2017 Mar;101(5):1999-2019. doi: 10.1007/s00253-016-7885-x. Epub 2016 Nov 11.

PMID:
27837314
12.

Isolated splenic metastasis from clear cell renal carcinoma - A case report.

Kaur Grewal S, Doley RP, Roy K, Singla M, Malhotra M, Bawa AS, Kapoor R, Wig JD.

Int J Surg Case Rep. 2016;29:44-46. doi: 10.1016/j.ijscr.2016.10.045. Epub 2016 Oct 25.

13.

The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease.

Evans JC, Malhotra M, Cryan JF, O'Driscoll CM.

Br J Pharmacol. 2016 Nov;173(21):3041-3079. doi: 10.1111/bph.13576. Epub 2016 Sep 23. Review.

14.

Oligonucleotide conjugates - Candidates for gene silencing therapeutics.

Gooding M, Malhotra M, Evans JC, Darcy R, O'Driscoll CM.

Eur J Pharm Biopharm. 2016 Oct;107:321-40. doi: 10.1016/j.ejpb.2016.07.024. Epub 2016 Aug 10. Review.

PMID:
27521696
15.

Folate-targeted amphiphilic cyclodextrin.siRNA nanoparticles for prostate cancer therapy exhibit PSMA mediated uptake, therapeutic gene silencing in vitro and prolonged circulation in vivo.

Evans JC, Malhotra M, Guo J, O'Shea JP, Hanrahan K, O'Neill A, Landry WD, Griffin BT, Darcy R, Watson RW, O'Driscoll CM.

Nanomedicine. 2016 Nov;12(8):2341-2351. doi: 10.1016/j.nano.2016.06.014. Epub 2016 Jul 4.

PMID:
27389146
16.

A novel, anisamide-targeted cyclodextrin nanoformulation for siRNA delivery to prostate cancer cells expressing the sigma-1 receptor.

Fitzgerald KA, Malhotra M, Gooding M, Sallas F, Evans JC, Darcy R, O'Driscoll CM.

Int J Pharm. 2016 Feb 29;499(1-2):131-145. doi: 10.1016/j.ijpharm.2015.12.055. Epub 2015 Dec 22.

PMID:
26721726
17.

Human Serum Albumin Nanoparticles for Use in Cancer Drug Delivery: Process Optimization and In Vitro Characterization.

Lomis N, Westfall S, Farahdel L, Malhotra M, Shum-Tim D, Prakash S.

Nanomaterials (Basel). 2016 Jun 15;6(6). pii: E116. doi: 10.3390/nano6060116.

18.

Designing a broad-spectrum integrative approach for cancer prevention and treatment.

Block KI, Gyllenhaal C, Lowe L, Amedei A, Amin ARMR, Amin A, Aquilano K, Arbiser J, Arreola A, Arzumanyan A, Ashraf SS, Azmi AS, Benencia F, Bhakta D, Bilsland A, Bishayee A, Blain SW, Block PB, Boosani CS, Carey TE, Carnero A, Carotenuto M, Casey SC, Chakrabarti M, Chaturvedi R, Chen GZ, Chen H, Chen S, Chen YC, Choi BK, Ciriolo MR, Coley HM, Collins AR, Connell M, Crawford S, Curran CS, Dabrosin C, Damia G, Dasgupta S, DeBerardinis RJ, Decker WK, Dhawan P, Diehl AME, Dong JT, Dou QP, Drew JE, Elkord E, El-Rayes B, Feitelson MA, Felsher DW, Ferguson LR, Fimognari C, Firestone GL, Frezza C, Fujii H, Fuster MM, Generali D, Georgakilas AG, Gieseler F, Gilbertson M, Green MF, Grue B, Guha G, Halicka D, Helferich WG, Heneberg P, Hentosh P, Hirschey MD, Hofseth LJ, Holcombe RF, Honoki K, Hsu HY, Huang GS, Jensen LD, Jiang WG, Jones LW, Karpowicz PA, Keith WN, Kerkar SP, Khan GN, Khatami M, Ko YH, Kucuk O, Kulathinal RJ, Kumar NB, Kwon BS, Le A, Lea MA, Lee HY, Lichtor T, Lin LT, Locasale JW, Lokeshwar BL, Longo VD, Lyssiotis CA, MacKenzie KL, Malhotra M, Marino M, Martinez-Chantar ML, Matheu A, Maxwell C, McDonnell E, Meeker AK, Mehrmohamadi M, Mehta K, Michelotti GA, Mohammad RM, Mohammed SI, Morre DJ, Muralidhar V, Muqbil I, Murphy MP, Nagaraju GP, Nahta R, Niccolai E, Nowsheen S, Panis C, Pantano F, Parslow VR, Pawelec G, Pedersen PL, Poore B, Poudyal D, Prakash S, Prince M, Raffaghello L, Rathmell JC, Rathmell WK, Ray SK, Reichrath J, Rezazadeh S, Ribatti D, Ricciardiello L, Robey RB, Rodier F, Rupasinghe HPV, Russo GL, Ryan EP, Samadi AK, Sanchez-Garcia I, Sanders AJ, Santini D, Sarkar M, Sasada T, Saxena NK, Shackelford RE, Shantha Kumara HMC, Sharma D, Shin DM, Sidransky D, Siegelin MD, Signori E, Singh N, Sivanand S, Sliva D, Smythe C, Spagnuolo C, Stafforini DM, Stagg J, Subbarayan PR, Sundin T, Talib WH, Thompson SK, Tran PT, Ungefroren H, Vander Heiden MG, Venkateswaran V, Vinay DS, Vlachostergios PJ, Wang Z, Wellen KE, Whelan RL, Yang ES, Yang H, Yang X, Yaswen P, Yedjou C, Yin X, Zhu J, Zollo M.

Semin Cancer Biol. 2015 Dec;35 Suppl:S276-S304. doi: 10.1016/j.semcancer.2015.09.007. Review.

19.

Cytotoxicity of alkaloids isolated from Argemone mexicana on SW480 human colon cancer cell line.

Singh S, Verma M, Malhotra M, Prakash S, Singh TD.

Pharm Biol. 2016;54(4):740-5. doi: 10.3109/13880209.2015.1073334. Epub 2015 Oct 6.

PMID:
26439487
20.

Life in 3D is never flat: 3D models to optimise drug delivery.

Fitzgerald KA, Malhotra M, Curtin CM, O' Brien FJ, O' Driscoll CM.

J Control Release. 2015 Oct 10;215:39-54. doi: 10.1016/j.jconrel.2015.07.020. Epub 2015 Jul 26. Review.

PMID:
26220617

Supplemental Content

Loading ...
Support Center